Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Innovations in Clinical Neuroscience
|
August 26, 2014
Anosognosia in schizophrenia: hidden in plain sight
Douglas S Lehrer, Jennifer Lorenz
The Journal of Steroid Biochemistry and Molecular Biology
|
July 31, 2017
Vitamin D, cod liver oil, sunshine, and phototherapy: Safe, effective and forgotten tools for treating and curing tuberculosis infections - A comprehensive review
Patrick J McCullough, Douglas S Lehrer
The Journal of Steroid Biochemistry and Molecular Biology
|
January 7, 2019
Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience
Patrick J McCullough, Douglas S Lehrer, Jeffrey Amend
Schizophrenia Bulletin
|
November 18, 2008
Psychiatric comorbidities and schizophrenia
Peter F Buckley, Brian J Miller, Douglas S Lehrer, et al.
Psychiatry Research
|
November 2, 2017
Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia
Scott Gspandl, Ryan P Peirson, Ramzi W Nahhas, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 14, 2023
Normal 24-hour urine calcium concentrations after long-term daily oral intake of vitamin D in doses ranging from 5000 to 50,000 international units in 14 adult hospitalized psychiatric patients
Steven J Repas, Benjamin N Schmeusser, William P McCullough, et al.
Brain Imaging and Behavior
|
December 8, 2018
Dopamine receptor density and white mater integrity: <sup>18</sup>F-fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects
Serge A Mitelman, Monte S Buchsbaum, Bradley T Christian, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
September 26, 2019
Positive association between cerebral grey matter metabolism and dopamine D<sub>2</sub>/D<sub>3</sub> receptor availability in healthy and schizophrenia subjects: An <sup>18</sup>F-fluorodeoxyglucose and <sup>18</sup>F-fallypride positron emission tomography study
Serge A Mitelman, Monte S Buchsbaum, Bradley T Christian, et al.
Neuroimage
|
February 14, 2006
Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task
Bradley T Christian, Douglas S Lehrer, Bingzhi Shi, et al.
Law and Human Behavior
|
September 23, 2009
Quantifying the accuracy of forensic examiners in the absence of a "gold standard"
Douglas Mossman, Michael D Bowen, David J Vanness, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Innovations in Clinical Neuroscience
|
August 26, 2014
Anosognosia in schizophrenia: hidden in plain sight
Douglas S Lehrer, Jennifer Lorenz
The Journal of Steroid Biochemistry and Molecular Biology
|
July 31, 2017
Vitamin D, cod liver oil, sunshine, and phototherapy: Safe, effective and forgotten tools for treating and curing tuberculosis infections - A comprehensive review
Patrick J McCullough, Douglas S Lehrer
The Journal of Steroid Biochemistry and Molecular Biology
|
January 7, 2019
Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience
Patrick J McCullough, Douglas S Lehrer, Jeffrey Amend
Schizophrenia Bulletin
|
November 18, 2008
Psychiatric comorbidities and schizophrenia
Peter F Buckley, Brian J Miller, Douglas S Lehrer, et al.
Psychiatry Research
|
November 2, 2017
Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia
Scott Gspandl, Ryan P Peirson, Ramzi W Nahhas, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
May 14, 2023
Normal 24-hour urine calcium concentrations after long-term daily oral intake of vitamin D in doses ranging from 5000 to 50,000 international units in 14 adult hospitalized psychiatric patients
Steven J Repas, Benjamin N Schmeusser, William P McCullough, et al.
Brain Imaging and Behavior
|
December 8, 2018
Dopamine receptor density and white mater integrity: <sup>18</sup>F-fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects
Serge A Mitelman, Monte S Buchsbaum, Bradley T Christian, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
September 26, 2019
Positive association between cerebral grey matter metabolism and dopamine D<sub>2</sub>/D<sub>3</sub> receptor availability in healthy and schizophrenia subjects: An <sup>18</sup>F-fluorodeoxyglucose and <sup>18</sup>F-fallypride positron emission tomography study
Serge A Mitelman, Monte S Buchsbaum, Bradley T Christian, et al.
Neuroimage
|
February 14, 2006
Measuring dopamine neuromodulation in the thalamus: using [F-18]fallypride PET to study dopamine release during a spatial attention task
Bradley T Christian, Douglas S Lehrer, Bingzhi Shi, et al.
Law and Human Behavior
|
September 23, 2009
Quantifying the accuracy of forensic examiners in the absence of a "gold standard"
Douglas Mossman, Michael D Bowen, David J Vanness, et al.
Page
of 3